Expression and characterization of cloned human bombesin receptors

RV Benya, T Kusui, TK Pradhan, JF Battey and RT Jensen

Digestive Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892.

Little is known about the pharmacology or cell biology of human bombesin (Bn) receptors, because they are usually present at low levels and both subtypes are frequently present in the same tissues. Human gastrin-releasing peptide (GRP) receptors (huGRP-R) and human neuromedin B (NMB) receptors (huNMB-R) were stably transfected into BALB/3T3 fibroblasts. Both receptor types were glycosylated, with 35% of the huGRP-R and 38% of the huNMB-R representing carbohydrate residues. The extent of glycosylation of the transfected huGRP-R was the same as that seen in the human glioblastoma cell line U-118. Radiolabeled agonist ligands were rapidly internalized, whereas noninternalized ligand readily dissociated in a temperature-dependent fashion. The affinities of various agonists for binding to the huGRP-R were Bn (Ki = 1.4 +/- 0.2 nM) = 4 x GRP = 300 x NMB. In contrast, affinities for the huNMB-R were NMB (Ki = 8.1 +/- 5.2 nM) = 4 x Bn = 600 x GRP. [F5-D-Phe6,D-Ala11]Bn(6-13)methyl ester was the most potent huGRP-R antagonist, whereas D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Nal-NH2 was the most potent huNMB-R antagonist. Agonist binding to either receptor type caused activation of phospholipase C and increased cellular [3H]inositol phosphate levels. GRP was potent at increasing [3H]inositol phosphate generation in cells expressing the huGRP-R (EC50 = 13.6 +/- 1.3 nM), whereas NMB was similarly potent when acting upon cells expressing the huNMB-R (EC50 = 9.3 +/- 1.4 nM). However, neither receptor type, when stimulated with agonist, caused an increase in cAMP levels. These data show that stably transfected huGRP-R exhibit similar pharmacology for agonists and antagonists, are appropriately glycosylated, and function similarly with respect to their ability to alter biological activity, compared with natively expressed receptors. Minimal native huNMB-R data are available for comparison, but in general the huNMB-R is similar to the rat NMB receptor in its pharmacology and cell biology.

Volume 47, Issue 1, pp. 10-20, 01/01/1995
Copyright © 1995 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				W. Guojun, G. Wei, O. Kedong, H. Yi, X. Yanfei, C. Qingmei, Z. Yankai, W. Jie, F. Hao, L. Taiming, et al. A novel vaccine targeting gastrin-releasing peptide: efficient inhibition of breast cancer growth in vivo Endocr. Relat. Cancer, March 1, 2008; 15(1): 149 - 159. [Abstract] [Full Text] [PDF]

				R. T. Jensen, J. F. Battey, E. R. Spindel, and R. V. Benya International Union of Pharmacology. LXVIII. Mammalian Bombesin Receptors: Nomenclature, Distribution, Pharmacology, Signaling, and Functions in Normal and Disease States Pharmacol. Rev., March 1, 2008; 60(1): 1 - 42. [Abstract] [Full Text] [PDF]

				L. Taglia, D. Matusiak, K. A. Matkowskyj, and R. V. Benya Gastrin-releasing peptide mediates its morphogenic properties in human colon cancer by upregulating intracellular adhesion protein-1 (ICAM-1) via focal adhesion kinase Am J Physiol Gastrointest Liver Physiol, January 1, 2007; 292(1): G182 - G190. [Abstract] [Full Text] [PDF]

				S. A. Mantey, N. Gonzalez, M. Schumann, T. K. Pradhan, L. Shen, D. H. Coy, and R. T. Jensen Identification of Bombesin Receptor Subtype-Specific Ligands: Effect of N-Methyl Scanning, Truncation, Substitution, and Evaluation of Putative Reported Selective Ligands J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 980 - 989. [Abstract] [Full Text] [PDF]

				T. W. Moody, L.-C. Sun, S. A. Mantey, T. Pradhan, L. V. Mackey, N. Gonzales, J. A. Fuselier, D. H. Coy, and R. T. Jensen In Vitro and in Vivo Antitumor Effects of Cytotoxic Camptothecin-Bombesin Conjugates Are Mediated by Specific Interaction with Cellular Bombesin Receptors J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 1265 - 1272. [Abstract] [Full Text] [PDF]

				K. Ashour, L. Shan, J. H. Lee, W. Schlicher, K. Wada, E. Wada, and M. E. Sunday Bombesin Inhibits Alveolarization and Promotes Pulmonary Fibrosis in Newborn Mice Am. J. Respir. Crit. Care Med., June 15, 2006; 173(12): 1377 - 1385. [Abstract] [Full Text] [PDF]

				T. Maina, B. A. Nock, H. Zhang, A. Nikolopoulou, B. Waser, J.-C. Reubi, and H. R. Maecke Species Differences of Bombesin Analog Interactions with GRP-R Define the Choice of Animal Models in the Development of GRP-R-Targeting Drugs J. Nucl. Med., May 1, 2005; 46(5): 823 - 830. [Abstract] [Full Text] [PDF]

				D. Matusiak, S. Glover, R. Nathaniel, K. Matkowskyj, J. Yang, and R. V. Benya Neuromedin B and its receptor are mitogens in both normal and malignant epithelial cells lining the colon Am J Physiol Gastrointest Liver Physiol, April 1, 2005; 288(4): G718 - G728. [Abstract] [Full Text] [PDF]

				J. R. Grider Gastrin-releasing peptide is a modulatory neurotransmitter of the descending phase of the peristaltic reflex Am J Physiol Gastrointest Liver Physiol, December 1, 2004; 287(6): G1109 - G1115. [Abstract] [Full Text] [PDF]

				S. A. Mantey, D. H. Coy, L. K. Entsuah, and R. T. Jensen Development of Bombesin Analogs with Conformationally Restricted Amino Acid Substitutions with Enhanced Selectivity for the Orphan Receptor Human Bombesin Receptor Subtype 3 J. Pharmacol. Exp. Ther., September 1, 2004; 310(3): 1161 - 1170. [Abstract] [Full Text] [PDF]

				T. W. Moody, S. A. Mantey, T. K. Pradhan, M. Schumann, T. Nakagawa, A. Martinez, J. Fuselier, D. H. Coy, and R. T. Jensen Development of High Affinity Camptothecin-Bombesin Conjugates That Have Targeted Cytotoxicity for Bombesin Receptor-containing Tumor Cells J. Biol. Chem., May 28, 2004; 279(22): 23580 - 23589. [Abstract] [Full Text] [PDF]

				M. Subramaniam, K. Sugiyama, D. H. Coy, Y. Kong, Y. E. Miller, P. F. Weller, K. Wada, E. Wada, and M. E. Sunday Bombesin-like Peptides and Mast Cell Responses: Relevance to Bronchopulmonary Dysplasia? Am. J. Respir. Crit. Care Med., September 1, 2003; 168(5): 601 - 611. [Abstract] [Full Text] [PDF]

				K. A. Matkowskyj, R. Cox, R. T. Jensen, and R. V. Benya Quantitative Immunohistochemistry by Measuring Cumulative Signal Strength Accurately Measures Receptor Number J. Histochem. Cytochem., February 1, 2003; 51(2): 205 - 214. [Abstract] [Full Text] [PDF]

				K. Tokita, S. J. Hocart, D. H. Coy, and R. T. Jensen Molecular Basis of the Selectivity of Gastrin-Releasing Peptide Receptor for Gastrin-Releasing Peptide Mol. Pharmacol., June 1, 2002; 61(6): 1435 - 1443. [Abstract] [Full Text] [PDF]

				R. V. Benya, T. Kusui, T. Katsuno, T. Tsuda, S. A. Mantey, J. F. Battey, and R. T. Jensen Glycosylation of the Gastrin-Releasing Peptide Receptor and Its Effect on Expression, G Protein Coupling, and Receptor Modulatory Processes Mol. Pharmacol., April 13, 2001; 58(6): 1490 - 1501. [Abstract] [Full Text]

				R. E. Carroll, D. Ostrovskiy, S. Lee, A. Danilkovich, and R. V. Benya Characterization of Gastrin-Releasing Peptide and Its Receptor Aberrantly Expressed by Human Colon Cancer Cell Lines Mol. Pharmacol., September 1, 2000; 58(3): 601 - 607. [Abstract] [Full Text]

				A. PANSKY, A. DE WEERTH, E. FASLER-KAN, J.-L. BOULAY, M. SCHULZ, S. KETTERER, C. SELCK, C. BEGLINGER, T. VON SCHRENCK, and P. HILDEBRAND Gastrin Releasing Peptide-Preferring Bombesin Receptors Mediate Growth of Human Renal Cell Carcinoma J. Am. Soc. Nephrol., August 1, 2000; 11(8): 1409 - 1418. [Abstract] [Full Text]

				R. L. Emanuel, J. S. Torday, Q. Mu, N. Asokananthan, K. A. Sikorski, and M. E. Sunday Bombesin-like peptides and receptors in normal fetal baboon lung: roles in lung growth and maturation Am J Physiol Lung Cell Mol Physiol, November 1, 1999; 277(5): L1003 - L1017. [Abstract] [Full Text] [PDF]

				X. Jian, E. Sainz, W. A. Clark, R. T. Jensen, J. F. Battey, and J. K. Northup The Bombesin Receptor Subtypes Have Distinct G Protein Specificities J. Biol. Chem., April 23, 1999; 274(17): 11573 - 11581. [Abstract] [Full Text] [PDF]

				R. V. Benya, J. A. Marrero, D. A. Ostrovskiy, A. Koutsouris, and G. Hecht Human colonic epithelial cells express galanin-1 receptors, which when activated cause Cl- secretion Am J Physiol Gastrointest Liver Physiol, January 1, 1999; 276(1): G64 - G72. [Abstract] [Full Text] [PDF]

				R. R. Ryan, H. C. Weber, W. Hou, E. Sainz, S. A. Mantey, J. F. Battey, D. H. Coy, and R. T. Jensen Ability of Various Bombesin Receptor Agonists and Antagonists to Alter Intracellular Signaling of the Human Orphan Receptor BRS-3 J. Biol. Chem., May 29, 1998; 273(22): 13613 - 13624. [Abstract] [Full Text] [PDF]

				S. A. Mantey, H. C. Weber, E. Sainz, M. Akeson, R. R. Ryan, T. K. Pradhan, R. P. Searles, E. R. Spindel, J. F. Battey, D. H. Coy, et al. Discovery of a High Affinity Radioligand for the Human Orphan Receptor, Bombesin Receptor Subtype 3, Which Demonstrates That It Has a Unique Pharmacology Compared with Other Mammalian Bombesin Receptors J. Biol. Chem., October 10, 1997; 272(41): 26062 - 26071. [Abstract] [Full Text] [PDF]

				G. Gaudriault, D. Nouel, C. Dal Farra, A. Beaudet, and J.-P. Vincent Receptor-induced Internalization of Selective Peptidicµand delta Opioid Ligands J. Biol. Chem., January 31, 1997; 272(5): 2880 - 2888. [Abstract] [Full Text] [PDF]

				S. A. Mantey, D. H. Coy, T. K. Pradhan, H. Igarashi, I. M. Rizo, L. Shen, W. Hou, S. J. Hocart, and R. T. Jensen Rational Design of a Peptide Agonist That Interacts Selectively with the Orphan Receptor, Bombesin Receptor Subtype 3 J. Biol. Chem., March 16, 2001; 276(12): 9219 - 9229. [Abstract] [Full Text] [PDF]